by GlobeNewsWire | Jun 22, 2016 | Globe Newswire
VANCOUVER, Washington, June 22, 2016 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTC.QB:CYDY), a biotechnology company focused on the development of new monoclonal antibody therapies for combating human immunodeficiency virus (HIV) infection, announces the availability of...
by GlobeNewsWire | May 11, 2016 | Globe Newswire
BERKELEY HEIGHTS, N.J., May 11, 2016 (GLOBE NEWSWIRE) — Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) (NASDAQ:CYCCP) (“Cyclacel” or the “Company”), a biopharmaceutical company developing oral therapies that target the various phases of...
by GlobeNewsWire | May 10, 2016 | Globe Newswire
WARREN, N.J., May 10, 2016 (GLOBE NEWSWIRE) — Bellerophon Therapeutics, Inc. (Nasdaq:BLPH), a clinical-stage biotherapeutics company, today reported financial results for the first quarter ended March 31, 2016 and provided a business update. “During the first...
by GlobeNewsWire | Apr 20, 2016 | Globe Newswire
New Data Shows Durable and Consistent Effects on Mean Annualized Growth Velocityfor up to 12 months with Increases of 46%-65% from Baseline Phase 3 Randomized Controlled Study Planned to Start at End of 2016 SAN RAFAEL, Calif., April 20, 2016 (GLOBE NEWSWIRE) —...
by GlobeNewsWire | Apr 18, 2016 | Globe Newswire
VANCOUVER, Wash., April 18, 2016 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTC.QB:CYDY), a biotechnology company focused on the development of new antibody therapies for combating human immunodeficiency virus (HIV) infection, announces that 10 HIV-infected patients in...